Xcell Biosciences
VerifiedBuilding products that enable propagation and gene editing in challenging cell types for clinical research and cell therapy applications.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$110—165m (Dealroom.co estimates Jan 2022.)
San Francisco California (HQ)
Authorizing premium user...